 | • レポートコード：MRC23Q38150 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のPEG-rhG-CSF市場について調査・分析し、世界のPEG-rhG-CSF市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（バイアル、プレフィルド）、用途別セグメント分析（予防、治療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Amgen、Apotex、Coherus BioSciences、Fresenius Kabi Deutschland、Juta Pharma、Mundipharma、Novartis、Pfizer、Viatris、Hengrui Pharmaceuticals、Lunan Pharmaceutical、Qilu Pharmaceutical、CSPCなどが含まれています。世界のPEG-rhG-CSF市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、PEG-rhG-CSF市場規模を推定する際に考慮しました。本レポートは、PEG-rhG-CSFの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、PEG-rhG-CSFに関するビジネス上の意思決定に役立てることを目的としています。 ・PEG-rhG-CSF市場の概要 - 製品の定義 - PEG-rhG-CSFのタイプ別セグメント - 世界のPEG-rhG-CSF市場規模：タイプ別分析（バイアル、プレフィルド） - PEG-rhG-CSFの用途別セグメント - 世界のPEG-rhG-CSF市場規模：用途別分析（予防、治療） - 世界のPEG-rhG-CSF市場規模予測（2018年-2029年） - PEG-rhG-CSFの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - PEG-rhG-CSF市場の競争状況およびトレンド ・PEG-rhG-CSFの地域別市場規模 - 北米のPEG-rhG-CSF市場規模（2018年-2029年） - アメリカのPEG-rhG-CSF市場規模（2018年-2029年） - ヨーロッパのPEG-rhG-CSF市場規模（2018年-2029年） - アジア太平洋のPEG-rhG-CSF市場規模（2018年-2029年） - 中国のPEG-rhG-CSF市場規模（2018年-2029年） - 日本のPEG-rhG-CSF市場規模（2018年-2029年） - 韓国のPEG-rhG-CSF市場規模（2018年-2029年） - インドのPEG-rhG-CSF市場規模（2018年-2029年） - オーストラリアのPEG-rhG-CSF市場規模（2018年-2029年） - 中南米のPEG-rhG-CSF市場規模（2018年-2029年） - 中東・アフリカのPEG-rhG-CSF市場規模（2018年-2029年） ・タイプ別セグメント：バイアル、プレフィルド - 世界のPEG-rhG-CSFのタイプ別販売量（2018年-2023年） - 世界のPEG-rhG-CSFのタイプ別売上（2018年-2023年） - 世界のPEG-rhG-CSFのタイプ別価格 ・用途別セグメント：予防、治療 - 世界のPEG-rhG-CSFの用途別販売量（2018年-2023年） - 世界のPEG-rhG-CSFの用途別売上（2018年-2023年） - 世界のPEG-rhG-CSFの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Amgen、Apotex、Coherus BioSciences、Fresenius Kabi Deutschland、Juta Pharma、Mundipharma、Novartis、Pfizer、Viatris、Hengrui Pharmaceuticals、Lunan Pharmaceutical、Qilu Pharmaceutical、CSPC ・産業チェーンと販売チャネルの分析 - PEG-rhG-CSF産業チェーン分析 - PEG-rhG-CSFの主要原材料 - PEG-rhG-CSFの販売チャネル - PEG-rhG-CSFのディストリビューター - PEG-rhG-CSFの主要顧客 ・PEG-rhG-CSF市場ダイナミクス - PEG-rhG-CSFの業界動向 - PEG-rhG-CSF市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global PEG-rhG-CSF market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for PEG-rhG-CSF is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PEG-rhG-CSF is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of PEG-rhG-CSF include Amgen, Apotex, Coherus BioSciences, Fresenius Kabi Deutschland, Juta Pharma, Mundipharma, Novartis, Pfizer and Viatris, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PEG-rhG-CSF, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEG-rhG-CSF.
The PEG-rhG-CSF market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PEG-rhG-CSF market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEG-rhG-CSF manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Amgen
Apotex
Coherus BioSciences
Fresenius Kabi Deutschland
Juta Pharma
Mundipharma
Novartis
Pfizer
Viatris
Hengrui Pharmaceuticals
Lunan Pharmaceutical
Qilu Pharmaceutical
CSPC
Segment by Type
Vials
Prefilled
Segment by Application
Prevention
Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEG-rhG-CSF manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEG-rhG-CSF in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 PEG-rhG-CSF Market Overview
1.1 Product Overview and Scope of PEG-rhG-CSF
1.2 PEG-rhG-CSF Segment by Type
1.2.1 Global PEG-rhG-CSF Market Value Comparison by Type (2023-2029)
1.2.2 Vials
1.2.3 Prefilled
1.3 PEG-rhG-CSF Segment by Application
1.3.1 Global PEG-rhG-CSF Market Value by Application: (2023-2029)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global PEG-rhG-CSF Market Size Estimates and Forecasts
1.4.1 Global PEG-rhG-CSF Revenue 2018-2029
1.4.2 Global PEG-rhG-CSF Sales 2018-2029
1.4.3 Global PEG-rhG-CSF Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PEG-rhG-CSF Market Competition by Manufacturers
2.1 Global PEG-rhG-CSF Sales Market Share by Manufacturers (2018-2023)
2.2 Global PEG-rhG-CSF Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PEG-rhG-CSF Average Price by Manufacturers (2018-2023)
2.4 Global PEG-rhG-CSF Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PEG-rhG-CSF, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PEG-rhG-CSF, Product Type & Application
2.7 PEG-rhG-CSF Market Competitive Situation and Trends
2.7.1 PEG-rhG-CSF Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PEG-rhG-CSF Players Market Share by Revenue
2.7.3 Global PEG-rhG-CSF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PEG-rhG-CSF Retrospective Market Scenario by Region
3.1 Global PEG-rhG-CSF Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PEG-rhG-CSF Global PEG-rhG-CSF Sales by Region: 2018-2029
3.2.1 Global PEG-rhG-CSF Sales by Region: 2018-2023
3.2.2 Global PEG-rhG-CSF Sales by Region: 2024-2029
3.3 Global PEG-rhG-CSF Global PEG-rhG-CSF Revenue by Region: 2018-2029
3.3.1 Global PEG-rhG-CSF Revenue by Region: 2018-2023
3.3.2 Global PEG-rhG-CSF Revenue by Region: 2024-2029
3.4 North America PEG-rhG-CSF Market Facts & Figures by Country
3.4.1 North America PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PEG-rhG-CSF Sales by Country (2018-2029)
3.4.3 North America PEG-rhG-CSF Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PEG-rhG-CSF Market Facts & Figures by Country
3.5.1 Europe PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PEG-rhG-CSF Sales by Country (2018-2029)
3.5.3 Europe PEG-rhG-CSF Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PEG-rhG-CSF Market Facts & Figures by Country
3.6.1 Asia Pacific PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PEG-rhG-CSF Sales by Country (2018-2029)
3.6.3 Asia Pacific PEG-rhG-CSF Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PEG-rhG-CSF Market Facts & Figures by Country
3.7.1 Latin America PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PEG-rhG-CSF Sales by Country (2018-2029)
3.7.3 Latin America PEG-rhG-CSF Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PEG-rhG-CSF Market Facts & Figures by Country
3.8.1 Middle East and Africa PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PEG-rhG-CSF Sales by Country (2018-2029)
3.8.3 Middle East and Africa PEG-rhG-CSF Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global PEG-rhG-CSF Sales by Type (2018-2029)
4.1.1 Global PEG-rhG-CSF Sales by Type (2018-2023)
4.1.2 Global PEG-rhG-CSF Sales by Type (2024-2029)
4.1.3 Global PEG-rhG-CSF Sales Market Share by Type (2018-2029)
4.2 Global PEG-rhG-CSF Revenue by Type (2018-2029)
4.2.1 Global PEG-rhG-CSF Revenue by Type (2018-2023)
4.2.2 Global PEG-rhG-CSF Revenue by Type (2024-2029)
4.2.3 Global PEG-rhG-CSF Revenue Market Share by Type (2018-2029)
4.3 Global PEG-rhG-CSF Price by Type (2018-2029)
5 Segment by Application
5.1 Global PEG-rhG-CSF Sales by Application (2018-2029)
5.1.1 Global PEG-rhG-CSF Sales by Application (2018-2023)
5.1.2 Global PEG-rhG-CSF Sales by Application (2024-2029)
5.1.3 Global PEG-rhG-CSF Sales Market Share by Application (2018-2029)
5.2 Global PEG-rhG-CSF Revenue by Application (2018-2029)
5.2.1 Global PEG-rhG-CSF Revenue by Application (2018-2023)
5.2.2 Global PEG-rhG-CSF Revenue by Application (2024-2029)
5.2.3 Global PEG-rhG-CSF Revenue Market Share by Application (2018-2029)
5.3 Global PEG-rhG-CSF Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen PEG-rhG-CSF Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Apotex PEG-rhG-CSF Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Coherus BioSciences
6.3.1 Coherus BioSciences Corporation Information
6.3.2 Coherus BioSciences Description and Business Overview
6.3.3 Coherus BioSciences PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Coherus BioSciences PEG-rhG-CSF Product Portfolio
6.3.5 Coherus BioSciences Recent Developments/Updates
6.4 Fresenius Kabi Deutschland
6.4.1 Fresenius Kabi Deutschland Corporation Information
6.4.2 Fresenius Kabi Deutschland Description and Business Overview
6.4.3 Fresenius Kabi Deutschland PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Deutschland PEG-rhG-CSF Product Portfolio
6.4.5 Fresenius Kabi Deutschland Recent Developments/Updates
6.5 Juta Pharma
6.5.1 Juta Pharma Corporation Information
6.5.2 Juta Pharma Description and Business Overview
6.5.3 Juta Pharma PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Juta Pharma PEG-rhG-CSF Product Portfolio
6.5.5 Juta Pharma Recent Developments/Updates
6.6 Mundipharma
6.6.1 Mundipharma Corporation Information
6.6.2 Mundipharma Description and Business Overview
6.6.3 Mundipharma PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mundipharma PEG-rhG-CSF Product Portfolio
6.6.5 Mundipharma Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis PEG-rhG-CSF Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer PEG-rhG-CSF Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Viatris
6.9.1 Viatris Corporation Information
6.9.2 Viatris Description and Business Overview
6.9.3 Viatris PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Viatris PEG-rhG-CSF Product Portfolio
6.9.5 Viatris Recent Developments/Updates
6.10 Hengrui Pharmaceuticals
6.10.1 Hengrui Pharmaceuticals Corporation Information
6.10.2 Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Hengrui Pharmaceuticals PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hengrui Pharmaceuticals PEG-rhG-CSF Product Portfolio
6.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.11 Lunan Pharmaceutical
6.11.1 Lunan Pharmaceutical Corporation Information
6.11.2 Lunan Pharmaceutical PEG-rhG-CSF Description and Business Overview
6.11.3 Lunan Pharmaceutical PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lunan Pharmaceutical PEG-rhG-CSF Product Portfolio
6.11.5 Lunan Pharmaceutical Recent Developments/Updates
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Corporation Information
6.12.2 Qilu Pharmaceutical PEG-rhG-CSF Description and Business Overview
6.12.3 Qilu Pharmaceutical PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Qilu Pharmaceutical PEG-rhG-CSF Product Portfolio
6.12.5 Qilu Pharmaceutical Recent Developments/Updates
6.13 CSPC
6.13.1 CSPC Corporation Information
6.13.2 CSPC PEG-rhG-CSF Description and Business Overview
6.13.3 CSPC PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CSPC PEG-rhG-CSF Product Portfolio
6.13.5 CSPC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PEG-rhG-CSF Industry Chain Analysis
7.2 PEG-rhG-CSF Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PEG-rhG-CSF Production Mode & Process
7.4 PEG-rhG-CSF Sales and Marketing
7.4.1 PEG-rhG-CSF Sales Channels
7.4.2 PEG-rhG-CSF Distributors
7.5 PEG-rhG-CSF Customers
8 PEG-rhG-CSF Market Dynamics
8.1 PEG-rhG-CSF Industry Trends
8.2 PEG-rhG-CSF Market Drivers
8.3 PEG-rhG-CSF Market Challenges
8.4 PEG-rhG-CSF Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer